Impact Factor ISSN: 1837-9664
Research Paper Exosomes from Cancer-associated Fibroblasts Orchestrate Lung Metastasis of Breast Cancer via LncRNA LMAEP Full text PDF
Research Paper Radiation-induced SLAMF1 reconfigures the SLAM family receptors landscape in triple-negative breast cancer cells Full text PDF
Research Paper Per-patient Comparison of [68Ga]-FAPI-46 Versus [18F]FDG as PET Tracers in ER-positive Breast Cancer: Study Design of a Single-centre Prospective Study Full text PDF
Research Paper Prognostic value of neuro-related genes in colorectal cancer and their potential implications for immunotherapy Full text PDF
Research Paper Bevacizumab or Aflibercept in Combination with Second-Line FOLFIRI after Progression on FOLFOX Plus Bevacizumab in Metastatic Colorectal Cancer: A Comparative Study Full text PDF
Review Urine-derived induced pluripotent stem cells for non-invasive diagnosis of bladder cancer Full text PDF
Issue 9; 2026
Indexed in PubMed and SCI expanded; full texts in Europe PMC. ...
Radiation therapy is a powerful immunomodulator capable of transforming the tumor microenvironment (TME). Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1) is a cell surface receptor involved in various immune functions and cancer progression by regulating interactions with the immune microenvironment. However, the specific role of radiation in modulating the SLAM family within tumor cells remained poorly understood. Ionizing radiation ...
Background: The optimal anti-angiogenic strategy in the second-line treatment of metastatic colorectal cancer (mCRC) after progression on first-line FOLFOX plus bevacizumab remains unclear. We aimed to compare the efficacy and safety of FOLFIRI combined with bevacizumab or aflibercept in this well-defined clinical setting. Methods: In this retrospective single-center study, 152 patients with mCRC who progressed after at least four cycles of first-line ...